midomafetamine (MDMA) / Lykos Therapeutics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
midomafetamine (MDMA) / Multidisciplinary Association for Psychedelic Studies (MAPS)
NCT03181763: Evaluation of MDMA on Startle Response

Completed
1
34
US
Placebo, Midomafetamine, 3,4-methylenedioxymethamphetamine, MDMA, Acoustic startle
Lykos Therapeutics
Startle Response
08/20
08/20
NCT01404754: Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers

Completed
1
107
US
Lactose (inactive placebo), 3,4-methylenedioxymethamphetamine, midomafetamine, MDMA
Lykos Therapeutics
Psychological Effects of Study Drug
08/22
08/22
MPKF, NCT05147402: Food Effects on Bioavailability of MDMA in Healthy Volunteers

Completed
1
14
US
MDMA, 3,4-methylenedioxymethamphetamine, midomafetamine
Lykos Therapeutics
Pharmacokinetics
12/22
12/22
NCT03606538: MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function

Not yet recruiting
1
16
US
Midomafetamine, MDMA, 3,4-methylenedioxymethamphetamine
Lykos Therapeutics
Pharmacokinetics, Hepatic Impairment
12/28
12/28
NCT04073433: Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

Withdrawn
1
150
NA
Midomafetamine, 3,4-methylenedioxymethamphetamine, MDMA, Therapy
Lykos Therapeutics
Psychological Effects of Study Drug
12/25
12/25
NCT06066853: MDMA-assisted Therapy for Fibromyalgia

Not yet recruiting
1
20
US
MDMA
Spaulding Rehabilitation Hospital, Multidisciplinary Association for Psychedelic Studies
Fibromyalgia
03/26
12/26

Download Options